BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28129717)

  • 61. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review.
    Curtis KM; Mohllajee AP; Peterson HB
    Contraception; 2006 Feb; 73(2):189-94. PubMed ID: 16413849
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!).
    van der Arend BWH; van Casteren DS; Verhagen IE; MaassenVanDenBrink A; Terwindt GM
    Trials; 2024 Feb; 25(1):123. PubMed ID: 38360739
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
    Mendel A; Bernatsky S; Pineau CA; St-Pierre Y; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae SC; Wallace DJ; Merrill JT; Buyon J; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin P; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcón G; Manzi S; Nived O; Jönsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet E
    Rheumatology (Oxford); 2019 Jul; 58(7):1259-1267. PubMed ID: 30753683
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk?
    Calhoun AH
    Headache; 2017 Feb; 57(2):184-193. PubMed ID: 27774589
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined hormonal contraception and its effects on mood: a critical review.
    Schaffir J; Worly BL; Gur TL
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):347-55. PubMed ID: 27636867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral contraceptives in migraine therapy.
    Allais G; Castagnoli Gabellari I; De Lorenzo C; Mana O; Benedetto C
    Neurol Sci; 2011 May; 32 Suppl 1():S135-9. PubMed ID: 21533729
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of Estrogens in Menstrual Migraine.
    Nappi RE; Tiranini L; Sacco S; De Matteis E; De Icco R; Tassorelli C
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Review of migraine incidence and management in obstetrics and gynaecology.
    Tanos V; Raad EA; Berry KE; Toney ZA
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():248-255. PubMed ID: 31336231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of menstrual migraine; multidisciplinary or mono-disciplinary approach.
    Witteveen H; van den Berg P; Vermeulen G
    J Headache Pain; 2017 Dec; 18(1):45. PubMed ID: 28417308
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?
    Tiranini L; Cucinella L; Martella S; Bosoni D; Martini E; Nappi RE
    Expert Rev Neurother; 2023 Apr; 23(4):377-388. PubMed ID: 37038655
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current use of combined hormonal contraception is associated with glucose metabolism disorders in perimenopausal women.
    Mosorin ME; Haverinen A; Ollila MM; Nordström T; Jokelainen J; Keinänen-Kiukaanniemi S; Puukka K; Ruokonen A; Auvinen J; Piltonen T; Morin-Papunen L; Tapanainen JS
    Eur J Endocrinol; 2020 Dec; 183(6):619-626. PubMed ID: 33105101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Do women aged over 40 need different counseling on combined hormonal contraception?
    Mendoza N; Soto E; Sánchez-Borrego R
    Maturitas; 2016 May; 87():79-83. PubMed ID: 27013292
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hormonal contraception and migraine: clinical considerations.
    Faubion SS; Casey PM; Shuster LT
    Curr Pain Headache Rep; 2012 Oct; 16(5):461-6. PubMed ID: 22648178
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Jealousy in women with migraine: a cross-sectional case-control study.
    van Casteren DS; van Willigenburg FAC; MaassenVanDenBrink A; Terwindt GM
    J Headache Pain; 2020 May; 21(1):51. PubMed ID: 32393167
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Migraine: navigating the hormonal minefield.
    Afridi SK
    Pract Neurol; 2020 Apr; 20(2):115-121. PubMed ID: 31753858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.
    Houvèssou GM; Farías-Antúnez S; da Silveira MF
    Sex Reprod Healthc; 2021 Feb; 27():100587. PubMed ID: 33545506
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hormonal contraceptive options for women with headache: a review of the evidence.
    Edlow AG; Bartz D
    Rev Obstet Gynecol; 2010; 3(2):55-65. PubMed ID: 20842283
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of oral contraceptives on migraine.
    Whitty CW; Hockaday JM; Whitty MM
    Lancet; 1966 Apr; 1(7442):856-9. PubMed ID: 4159965
    [No Abstract]   [Full Text] [Related]  

  • 80. Contraception for women. First consultation for the pill.
    Jones ND
    BMJ; 2009 Oct; 339():b4061. PubMed ID: 19805463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.